Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
16/05/2024 | 13:00 | GlobeNewswire Inc. | Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® | NASDAQ:AXGN | Axogen Inc |
14/05/2024 | 13:00 | GlobeNewswire Inc. | Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference | NASDAQ:AXGN | Axogen Inc |
02/05/2024 | 13:00 | GlobeNewswire Inc. | Axogen, Inc Reports First Quarter 2024 Financial Results | NASDAQ:AXGN | Axogen Inc |
29/04/2024 | 22:50 | GlobeNewswire Inc. | Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ | NASDAQ:AXGN | Axogen Inc |
16/04/2024 | 13:00 | GlobeNewswire Inc. | Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 | NASDAQ:AXGN | Axogen Inc |
08/03/2024 | 23:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
08/03/2024 | 22:38 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:AXGN | Axogen Inc |
08/03/2024 | 00:12 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:AXGN | Axogen Inc |
06/03/2024 | 14:59 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:AXGN | Axogen Inc |
06/03/2024 | 14:53 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of 1933 | NASDAQ:AXGN | Axogen Inc |
06/03/2024 | 14:45 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:AXGN | Axogen Inc |
05/03/2024 | 13:00 | GlobeNewswire Inc. | Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results | NASDAQ:AXGN | Axogen Inc |
14/02/2024 | 21:22 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AXGN | Axogen Inc |
13/02/2024 | 22:30 | GlobeNewswire Inc. | Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 | NASDAQ:AXGN | Axogen Inc |
12/02/2024 | 19:21 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:AXGN | Axogen Inc |
02/02/2024 | 22:15 | GlobeNewswire Inc. | Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | NASDAQ:AXGN | Axogen Inc |
18/01/2024 | 23:00 | GlobeNewswire Inc. | Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap | NASDAQ:AXGN | Axogen Inc |
11/01/2024 | 23:10 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:AXGN | Axogen Inc |
05/01/2024 | 23:21 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:AXGN | Axogen Inc |
04/01/2024 | 22:45 | GlobeNewswire Inc. | Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 | NASDAQ:AXGN | Axogen Inc |
04/01/2024 | 22:40 | GlobeNewswire Inc. | Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 | NASDAQ:AXGN | Axogen Inc |
04/01/2024 | 22:35 | GlobeNewswire Inc. | Axogen Announces Promotions on Research and Development Team | NASDAQ:AXGN | Axogen Inc |
26/12/2023 | 22:15 | GlobeNewswire Inc. | Axogen, Inc. Appoints Kathy Weiler to its Board of Directors | NASDAQ:AXGN | Axogen Inc |
06/12/2023 | 13:00 | GlobeNewswire Inc. | Axogen Announces Transition of Finance Team Leadership | NASDAQ:AXGN | Axogen Inc |
01/12/2023 | 23:00 | GlobeNewswire Inc. | Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:AXGN | Axogen Inc |
20/11/2023 | 13:00 | GlobeNewswire Inc. | Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference | NASDAQ:AXGN | Axogen Inc |
07/11/2023 | 22:03 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:AXGN | Axogen Inc |
07/11/2023 | 13:00 | GlobeNewswire Inc. | Axogen, Inc. Reports 2023 Third Quarter Financial Results | NASDAQ:AXGN | Axogen Inc |
18/10/2023 | 13:00 | GlobeNewswire Inc. | Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023 | NASDAQ:AXGN | Axogen Inc |
05/09/2023 | 13:00 | GlobeNewswire Inc. | Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™ | NASDAQ:AXGN | Axogen Inc |